Key terms

About ALLK

Allakos, Inc. engages in the development of therapeutic antibodies. Its primary product is AK002, a monoclonal antibody used for the treatment of various eosinophil and mast cell related diseases such as eosinophilic gastritis, urticaria, severe allergic conjunctivitis, and indolent systemic mastocytosis. The company was founded by Christopher Bebbington, Nenad Tomasevic, Bruce S. Bochner, and Robert Schleimer in 2012 and is headquartered in San Carlos, CA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest ALLK news

Mar 19 1:38am ET Hold Rating on Allakos Amidst Cautious Optimism for AK006 Program by TipRanks Mar 14 6:35pm ET TD Cowen Remains a Hold on Allakos (ALLK) by TipRanks Mar 14 4:07pm ET Allakos says restructuring extends cash runway into mid-2026 by TipRanks Mar 14 4:05pm ET Allakos reports Q4 EPS (71c), consensus (47c) by TipRanks Feb 26 4:10pm ET Analysts’ Top Healthcare Picks: KalVista Pharmaceuticals (KALV), Allakos (ALLK) by TipRanks Feb 26 7:30am ET Allakos presents preclinical data on AK006 at AAAAI meeting by TipRanks Feb 12 8:19am ET Allakos Inc Reveals Breakthrough AK006 Data in Allergy Journal by TipRanks Feb 12 7:13am ET Allakos announces publication on AK006 mast cell inhibition by TipRanks Jan 19 11:24am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Jan 18 11:32am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Jan 17 6:46am ET Allakos price target lowered to $3 from $10 at JMP Securities by TipRanks Jan 17 5:47am ET Allakos price target lowered to $1 from $1.50 at Barclays by TipRanks Jan 17 5:04am ET Allakos downgraded to Hold from Buy at Jefferies by TipRanks Jan 16 2:51pm ET Allakos downgraded to Market Perform from Outperform at LifeSci Capital by TipRanks Jan 02 12:13pm ET The biotech stocks to own in 2024, according to Piper Sandler by TipRanks

No recent press releases are available for ALLK

ALLK Financials

1-year income & revenue

Key terms

ALLK Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

ALLK Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

NEW YORK, NEW YORK - FEBRUARY 08: A New York Community Bank stands in Brooklyn on February 08, 2024 in New York City. New York Community Bancorp, a regional lender, shed about 60% of its value over the past eight days and its credit rating has been downgraded to Junk by Moody's. (Photo by Spencer Platt/Getty Images)
Spencer Platt/Getty Images
US regional banks are still under pressure. That’s likely to continue
Trump Media, which runs the social media platform Truth Social, took the place of Digital World's place on the Nasdaq stock exchange in March.
Frank Franklin II/AP
Trump Media stock ends session 15% higher after two very bad days
Students at Highlands High School, work on a practice test at the ACT Boot Camp in Newport, Ky.
Patrick Reddy/The Enquirer/AP/File
Private equity finds its next bet: college admissions
In this photo illustration, Republican presidential candidate former President Donald Trump's social media platform Truth Social is shown on a cell phone on March 25, 2024 in Chicago, Illinois.
Scott Olson/Getty Images
Trump’s stock tumbles again after Truth Social announces it’s getting into streaming